Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Revenue

    Back to Income Statement
ORCHID PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹1,398 Cr₹819 Cr₹666 Cr₹560 Cr₹450 Cr

What is the latest Revenue of ORCHID PHARMA ?

The latest Revenue ratio of ORCHID PHARMA is ₹1,398 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹1,398 Cr
Mar2025₹819 Cr
Mar2024₹666 Cr
Mar2023₹560 Cr
Mar2022₹450 Cr

How is Revenue of ORCHID PHARMA Trending?

Years Revenue % Change
Mar2026 ₹1,398 Cr
70.57
Mar2025 ₹819 Cr
23.05
Mar2024 ₹666 Cr
19.00
Mar2023 ₹560 Cr
24.33
Mar2022 ₹450 Cr -

Compare Revenue of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹6,632.1 Cr 15.6% 11% 52.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,437.0 Cr -0.5% -3% 16% Stock Analytics
DIVIS LABORATORIES ₹248,054.0 Cr 1.6% 9.3% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,842.0 Cr 3.5% 2.3% 40.6% Stock Analytics
CIPLA ₹111,565.0 Cr 1.6% -3.2% -11.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,163.0 Cr 5.8% 3.2% -8.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

15.6%

11%

52.6%

SENSEX

0.7%

-3.9%

-8.9%


You may also like the below Video Courses